Rapid reduction of depressive symptoms with minimal dissociation: results from the KET01-02 and KET0...
Rapid reduction of depressive symptoms with minimal dissociation: results from the KET01-02 and KET01-03 trials with oral prolonged-release (PR) ketamine KET01
About this item
Full title
Author / Creator
Publisher
Paris: Cambridge University Press
Journal title
Language
English
Formats
Publication information
Publisher
Paris: Cambridge University Press
Subjects
More information
Scope and Contents
Contents
IntroductionCurrent ketamine-based therapies for treatment-resistant depression (TRD) often induce dissociative effects. A novel oral PR ketamine formulation (KET01) results in a low and delayed peak concentration of ketamine, high hydroxynorketamine concentration, and is associated with limited dissociative properties.ObjectivesTo investigate effi...
Alternative Titles
Full title
Rapid reduction of depressive symptoms with minimal dissociation: results from the KET01-02 and KET01-03 trials with oral prolonged-release (PR) ketamine KET01
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c471e04dcc4540548f180e77c503826b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c471e04dcc4540548f180e77c503826b
Other Identifiers
ISSN
0924-9338
E-ISSN
1778-3585
DOI
10.1192/j.eurpsy.2024.220
